Redwood City bio-analysis business Seer tops $1B valuation in $175M IPO

The company entered its first day on Nasdaq with an initial valuation of about $1.1 billion, nearly four times the valuation it got in a May funding.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.